A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo.
Trimethylpsoralen, psoralen and 8-methoxypsoralen were adminstered in 10 mg dosage orally to 37, 29 and 23 patients with vitiligo.  Complete improvement was noted in 8.9% and partial improvement was recorded in 59.5%.  The overall results produced by trimethylpsoralen and psoralen were superior to those of 8-methoxypsoralen.  There was no significant therapeutic difference noticed in regards to age, sex, duration and type of vitiligo.
D003374:Coumarins / Q000627:therapeutic use*; D005260:Female; D005363:Ficusin / Q000627:therapeutic use*; D005663:Furans / Q000627:therapeutic use; D006801:Humans; D008297:Male; D014307:Trioxsalen / Q000627:therapeutic use*; D014820:Vitiligo / Q000188:drug therapy*
D003374:Coumarins; D005663:Furans; D005363:Ficusin; D014307:Trioxsalen